Mounjaro in NYC & Long Island

If you’re a type 2 diabetic looking to lower your A1C and potentially lose weight, you may be a good candidate for Mounjaro in NYC & Long Island. Mounjaro is an injectable prescription medication used primarily to decrease blood sugar in patients with type 2 diabetes. Although Mounjaro is not FDA-approved as a weight-loss medication, it has been shown to help many individuals lose weight. This medication is meant to be combined with a healthy diet and a consistent exercise routine.

How Does Mounjaro Work?

Mounjaro, which is a brand name for tirzepatide, is the very first dual GIP/GLP-1 receptor agonist. This means that it works on both the glucose-dependent insulinotropic polypeptide receptors and the glucagon-like peptide-1 receptors. The medication works by increasing the body’s insulin production and reducing the amount of sugar produced by the liver. This effectively reduces blood sugar levels. Additionally, Mounjaro slows down food as it’s processed through the body, which makes you feel full longer and decreases your appetite. This typically leads to reduced caloric intake, which can result in weight loss.